REACH Act

Lower Health Care Costs Act (S.1895) Reauthorizing and Extending America's Community Health Act - REACH Act (H.R. 2328) Preserve Access to Affordable Generics and Biosimilars Act (S. 64/H.R. 2375) Protecting Jessica Grubbs Legacy Act (S. 1012) Overdose Prevention and Patient Safety Act (H.R. 2062) ACA Medicaid disproportionate share hospital (DSH) cuts Prescription Drug Price Transparency Act (H.R.1035) Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R. 803) Short on Competition Act (S. 844) Resident Physician Shortage Act of 2019 (H.R. 1763/S. 348) FAST Generics Act (H.R. 985) The Protecting Consumer Access to Generic Drugs Act of 2019 (H.R. 1499) The Fair and Immediate Release of Generic Drugs Act (H.R. 1506) The Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 (H.R. 938) The Orange Book Transparency Act of 2019 (H.R. 1503) The Purple Book Continuity Act of 2019 (H.R. 1520) Home infusion: 50401 of the Bipartisan Budget Act of 2018 (BBA) (Pub. L. 115-123) and section 5012 of the 21st Century Cures Act of 2016 (CURES) (Pub. L. 114-255) Phair Pricing Act (H.R. 1030) Improving Seniors' Timely Access to Care Act of 2019 (H.R. 3107) The Mitigating Emergency Drug Shortages (MEDS) Act (S.2723) Accountable Care in Rural America Act (H.R. 5212) Rural ACO Improvement Act (S.2648) Helping Medicaid Offer Maternity Services (H.R. 4996) Prescription Drug Pricing Reduction Act of 2019 (S. 2543) Stop STALLING Act (H.R. 2374) Reforming Evergreening and Manipulation that Extends Drug Years Act (S. 1209) Preventing Drug Shortages Act (H.R. 6080) Protecting Jessica Grubb's Legacy Act (S. 3374) Preserving Patient Access to Home Infusion Act (H.R. 6218/S. 3457) Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) Families First Coronavirus Response Act (H.R. 6201) Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) The HEROES Act (HR 6800)

Client expense: $810,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Surprise billing legislation: S. 1895, HR 2328, HR 5921

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Surprise billing legislation: S. 1895, HR 2328, HR 5921

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 6201, Families First Coronavirus Response Act, House, Senate H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act, House, Senate H.R.6800 - The Heroes Act, House, Senate HR 7617 - FY 2021 funding for the National Institutes of Health (NIH) and Health Resources Services Administration (HRSA); Title VII and Title VII health professions funding, Senate H.R. 2328 - Medicaid Disproportionate Share Payments - the Community Health Investment, Modernization, and Excellence Act of 2019 340B Drug Pricing Program Centers for Medicare & Medicaid Services proposed Radiation Oncology Alternative Payment Model Medicaid Fiscal Accountability Regulation (MFAR), CMS, HHS, House, Senate Medicaid Disproportionate Share Hospital (DSH), House, Senate Federal Medical Assistance Percentages (FMAP), House, Senate National Cancer Institute Designation, House, Senate

Client expense: $246,890 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), White House Office

HR 6395, National Defense Authorization Act S. 4049, National Defense Authorization Act HR 6666, COVID 19 Testing, Reaching and Contacting Everyone Act (TRACE Act) HR 1425, Patient Protection and Affordable Care Enhancement Act HR 6514, Worker Health Coverage Protection Act HR 6568, Coverage for COVID 19 Treatment Act HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) HR 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act (CARES Act) HR 6201, The Families First Coronavirus Response Act HR 5438, Cox, The End Valley Fever Now Act S. 2897, Warner, regarding the reauthorization of PCORI HR 5201, Matsui, regarding telehealth and behavioral health HR 2328, PCORI Reauthorization HR 2328, the No Surprises Act S. 1895, the Lower Health Care Costs Act HR 987 and S. 455, regarding outreach and education activities under the ACA HR 3439, regarding the reauthorization of PCORI House Resolution 271, regarding the Justice Departments position in Texas v. United States HR 2062 & S. 1012, regarding 42 CFR Part 2 and confidentiality of certain health information HR 1884, with provisions to stabilize and strengthen the ACA and the nongroup insurance market. S. 470, regarding a Medicare buy-in option for individuals aged 50-64 S. 489 and HR 1277, regarding a Medicaid buy-in option S. 1129, to establish a single payer system based on Medicare for All. HR 1384, to establish a single payer health care system HR 1425, regarding reinsurance funding under the ACA HR 986 and S. 466, regarding Section 1332 state waiver guidance. HR 1010, regarding Short Term Limited Duration Insurance policies HR 1143, regarding Short Term Limited Duration Insurance policies HR 861, regarding surprise billing

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Agency for Healthcare Research and Quality Public Health Services Act, Title VII re-authorization; HR2781 CARES Act Council on Graduate Medical Education HRSA Primary Care Medicine and Dentistry Advisory Committee Teaching Health Centers GME Program S. 192, S.304, S.1191, HR2815, HR2328, HR4378 Continuing Appropriations Act 2020, and Health Extenders Act of 2019 HR748 CARES Act National Health Service Corps; HR2328 Draft COVID-19 package #4; Health, Economic Assistance, Liability protections, and Schools (HEALS) Act; HR6800, HEROES Act S.4775 Delivering Immediate Relief to America's Families, Schools, and Small Business Act Consolidated Appropriations Act, 2021

Client expense: $60,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), President of the U.S., SENATE, Veterans Affairs, Dept of (VA)

General Issures regarding Executive Order 13950 - Combating Race and Sex Stereotyping H.R.1636 / S.2163 / Public Law 116-156 "Commission on the Social Status of Black Men and Boys Act"Section 2. (b) (3) S. 1531Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; provisions related to eliminate surprise billing S. 348/H.R. 1763 - Resident Physician Shortage Reduction Act of 2019; all provisions H.R. 3, Moving Forward Act H.R. 6201, Families First Coronavirus Response Act Eliminate Surprise billing (S 1895, HR 3630, HR 3502, S 1531, HR 5800, HR 5826) Support the Resident Physician Shortage Reduction Act of 2019 (S 348/HR1763) Support delaying the ACAs DSH cuts (HR2328) Opioid Workforce Act (H.R. 3414)

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE

Price transparency, out-of-network reimbursement of emergency medical services, surprise medical bills Opioids, pain management Federal funding for Substance Use Disorder treatments Drug Shortages H.R.451-Dont Break Up the T-Band Act of 2020 H.R.501-Poison Center Network Enhancement Act of 2019 H.R.861-End Surprise Billing Act of 2019 H.R.925-The Heroes Act H.R.1301-Mental Health Telemedicine Expansion Act H.R.1309-Workplace Violence Prevention for Health Care and Social Service Workers Act H.R.1418-Competitive Health Insurance Reform Act of 2019 H.R.1554-Resident Education Deferred Interest (REDI) Act H.R.1646-Helping Emergency Responders Overcome (HERO) Act H.R.1682-Improving Access to Medicare Coverage Act of 2019 H.R.1767-Excellence in Mental Health and Addiction Treatment Expansion Act H.R.2281-Easy Medication Access and Treatment (MAT) for Opioid Addiction Act H.R.2328-Reauthorizing and Extending Americas Community Health Act H.R.2464-End the Cycle of Violence Act of 2019 H.R.2482-Mainstreaming Addiction Treatment Act of 2019 H.R.2519-Improving Mental Health Access from the Emergency Department Act of 2019 H.R.2550-Prevent Blood Loss with Emergency Equipment Devices Act of 2019 H.R.2569-Comprehensive Addiction Resources Emergency Act of 2019 H.R.3107-Improving Seniors Timely Access to Care Act of 2019 H.R.3417-Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019 H.R.3502-Protecting People From Surprise Medical Bills Act H.R.3630-No Surprises Act H.R.3935-Protecting Patients Transportation to Care Act H.R.3984-Health Care Safety Net Enhancement Act of 2019 H.R.4194-National Suicide Hotline Designation Act of 2019 H.R.4861-Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 H.R.4932-Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2019 H.R.5619-Suicide Prevention Act H.R.5727-Research Empirical Solutions to End Ambulance Reversals from Closed Hospitals (RESEARCH) Act of 2020 H.R.5800-Ban Surprise Billing Act H.R.5826-Consumer Protections Against Surprise Medical Bills Act of 2020 H.R.5855-Bipartisan Solution to Cyclical Violence Act of 2020 H.R.6663-Truth in Healthcare Marketing Act of 2020 H.R.6800-Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R.6910-Emergency Room Hero and Patient Safety Act H.R.6930-Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020 H.R.7059-Coronavirus Provider Protection Act H.R.7255-Coronavirus Health Care Worker Wellness Act of 2020 H.R.7574-Strengthening Americas Strategic National Stockpile Act of 2020 H.R.7819-Eliminating the Provider Relief Fund Tax Penalties Act of 2020 H.R.8094-Dr. Lorna Breen Health Care Provider Protection Act H.R.8441-Frontlines Heroes Act H.R.8505-To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes H.R.8702-Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 S.289-Rural Physician Workforce Production Act of 2019 S.299-Geriatrics Workforce Improvement Act S.350-Competitive Health Insurance Reform Act of 2019 S.618-Medicare Choices Empowerment and Protection Act S.753-Improving Access to Medicare Coverage Act of 2019 S.824-Excellence in Mental Health and Addiction Treatment Expansion Act S.851-Workplace Violence Prevention for Health Care and Social Service Workers Act S.1199-Poison Center Network Enhancement Act of 2019 S.1266-Protecting Patients from Surprise Medical Bills Act S.1334-Improving Mental Health Access from the Emergency Department S.1350-Good Samaritan Health Professionals Act of 2019 S.1365-Comprehensive Addiction Resources Emergency Act of 2019 S.1531-Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1895-Lower Health Care Costs Act S.2074-Mainstreaming Addiction Treatment Act of 2019 S.2661-National Suicide Hotline Designation Act of 2020 S.2741-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 S.3006-Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 S.3143-Magnet Injury Prevention Act S.3198-Suicide Prevention Act S.3346-Prevent Blood Loss with Emergency Equipment Devices Act of 2020 S.4349-Dr. Lorna Breen Health Care Provider Protection Act S.5007-Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020

Client expense: $340,838 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Price transparency, out-of-network reimbursement of emergency medical services, surprise medical bills H.R.861-End Surprise Billing Act of 2019 H.R.1418-Competitive Health Insurance Reform Act of 2019 H.R.2328-Reauthorizing and Extending Americas Community Health Act H.R.3107-Improving Seniors Timely Access to Care Act of 2019 H.R.3502-Protecting People From Surprise Medical Bills Act H.R.3630-No Surprises Act H.R.5800-Ban Surprise Billing Act H.R.5826-Consumer Protections Against Surprise Medical Bills Act of 2020 S.350-Competitive Health Insurance Reform Act of 2019 S.1266-Protecting Patients from Surprise Medical Bills Act S.1531-Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1895-Lower Health Care Costs Act

Client expense: $340,838 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Price transparency, out-of-network reimbursement of emergency medical services, surprise medical bills H.R.861-End Surprise Billing Act of 2019 H.R.1418-Competitive Health Insurance Reform Act of 2019 H.R.2328-Reauthorizing and Extending Americas Community Health Act H.R.3107-Improving Seniors Timely Access to Care Act of 2019 H.R.3502-Protecting People From Surprise Medical Bills Act H.R.3630-No Surprises Act H.R.5800-Ban Surprise Billing Act H.R.5826-Consumer Protections Against Surprise Medical Bills Act of 2020 S.350-Competitive Health Insurance Reform Act of 2019 S.1266-Protecting Patients from Surprise Medical Bills Act S.1531-Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1895-Lower Health Care Costs Act

Client expense: $391,824 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Price transparency, out-of-network reimbursement of emergency medical services, surprise medical bills Opioids, pain management Federal funding for Substance Use Disorder treatments Drug Shortages H.R.451-Dont Break Up the T-Band Act of 2020 H.R.501-Poison Center Network Enhancement Act of 2019 H.R.861-End Surprise Billing Act of 2019 H.R.925-The Heroes Act H.R.1301-Mental Health Telemedicine Expansion Act H.R.1309-Workplace Violence Prevention for Health Care and Social Service Workers Act H.R.1418-Competitive Health Insurance Reform Act of 2019 H.R.1554-Resident Education Deferred Interest (REDI) Act H.R.1646-Helping Emergency Responders Overcome (HERO) Act H.R.1682-Improving Access to Medicare Coverage Act of 2019 H.R.1767-Excellence in Mental Health and Addiction Treatment Expansion Act H.R.2281-Easy Medication Access and Treatment (MAT) for Opioid Addiction Act H.R.2328-Reauthorizing and Extending Americas Community Health Act H.R.2464-End the Cycle of Violence Act of 2019 H.R.2482-Mainstreaming Addiction Treatment Act of 2019 H.R.2519-Improving Mental Health Access from the Emergency Department Act of 2019 H.R.2550-Prevent Blood Loss with Emergency Equipment Devices Act of 2019 H.R.2569-Comprehensive Addiction Resources Emergency Act of 2019 H.R.3107-Improving Seniors Timely Access to Care Act of 2019 H.R.3417-Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019 H.R.3502-Protecting People From Surprise Medical Bills Act H.R.3630-No Surprises Act H.R.3935-Protecting Patients Transportation to Care Act H.R.3984-Health Care Safety Net Enhancement Act of 2019 H.R.4194-National Suicide Hotline Designation Act of 2019 H.R.4861-Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 H.R.4932-Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2019 H.R.5619-Suicide Prevention Act H.R.5727-Research Empirical Solutions to End Ambulance Reversals from Closed Hospitals (RESEARCH) Act of 2020 H.R.5800-Ban Surprise Billing Act H.R.5826-Consumer Protections Against Surprise Medical Bills Act of 2020 H.R.5855-Bipartisan Solution to Cyclical Violence Act of 2020 H.R.6663-Truth in Healthcare Marketing Act of 2020 H.R.6800-Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R.6910-Emergency Room Hero and Patient Safety Act H.R.6930-Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020 H.R.7059-Coronavirus Provider Protection Act H.R.7255-Coronavirus Health Care Worker Wellness Act of 2020 H.R.7574-Strengthening Americas Strategic National Stockpile Act of 2020 H.R.7819-Eliminating the Provider Relief Fund Tax Penalties Act of 2020 H.R.8094-Dr. Lorna Breen Health Care Provider Protection Act S.289-Rural Physician Workforce Production Act of 2019 S.299-Geriatrics Workforce Improvement Act S.350-Competitive Health Insurance Reform Act of 2019 S.618-Medicare Choices Empowerment and Protection Act S.753-Improving Access to Medicare Coverage Act of 2019 S.824-Excellence in Mental Health and Addiction Treatment Expansion Act S.851-Workplace Violence Prevention for Health Care and Social Service Workers Act S.1199-Poison Center Network Enhancement Act of 2019 S.1266-Protecting Patients from Surprise Medical Bills Act S.1334-Improving Mental Health Access from the Emergency Department S.1350-Good Samaritan Health Professionals Act of 2019 S.1365-Comprehensive Addiction Resources Emergency Act of 2019 S.1531-Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1895-Lower Health Care Costs Act S.2074-Mainstreaming Addiction Treatment Act of 2019 S.2661-National Suicide Hotline Designation Act of 2020 S.2741-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 S.3006-Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 S.3143-Magnet Injury Prevention Act S.3198-Suicide Prevention Act S.3346-Prevent Blood Loss with Emergency Equipment Devices Act of 2020 S.4349-Dr. Lorna Breen Health Care Provider Protection Act

Client expense: $391,824 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 1959, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077/S. 2546, Safe Step Act. Support H.R. 1035, Prescription Drug Price Transparency Act. Support H.R. 985, Fair Access for Safe and Timely Generics Act. Support S. 476, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act. Support H.R. 1034/S. 640, Phair Pricing Act. Support S. 657, Drug Price Transparency Act Support H.R. 938, BLOCKING Act Support H.R. 2375/S. 64, Preserve Access to Affordable Generics & Biosimilars Act Support H.R. 1499, Protecting Consumer Access to Generic Drugs Act Support H.R. 2296/S. 1391, Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2069, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act. Support H.R. 2115, Public Disclosure of Drug Discounts Act Support H.R. 2376/S. 1227, Prescription Pricing for the People Act Support H.R. 1379/S. 560, Ensuring Lasting Smiles Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 3107, Improving Seniors Timely Access to Care Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Support S. 2443 Investment in Tomorrows Pediatric Health Care Workforce Act Support H.R. 1554, Resident Education Deferred Interest (REDI) Act. Advocate for the continued and increased funding of Community Health Centers. Lobby members of Congress to cosponsor H. Res. 323, which would support state, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and would express the sense of the House of Representatives that state, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. In the context of legislation to address surprise medical bills, advocate for an independent dispute resolution (IDR) process to resolve disputes between payers and physicians and against provisions that would set out-of-network reimbursement rates at a benchmark level. (H.R. 2328, H.R. 3502, S. 1531, S. 1895, H.R. 133) Support H.R. 4575, Improving Provider Directories Act, which would require group health plans and health insurance issuers offering group or individual health insurance coverage to establish a process to address inaccurate information listed in publicly accessible provider directories of such plans and issuers. Support the Creating Opportunities Now for Necessary and Effect Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/H.R. 4932), which would increase access to telehealth services. Support legislation to address drug shortages by providing additional authority to the Food and Drug Administration (FDA) to ensure a stable supply of medications (S. 2723, Mitigating Emergency Drug Shortages Act; H.R. 6080, Preventing Drug Shortages Act). Similar provisions to mitigate drug shortages included in CARES Act (H.R. 748, S. 3548). Request resources to provide personal protection equipment (PPE) and supplies and relief from Medicare payment sequester and relief from penalties in Merit-based Incentive Payment System (MIPS) under MACRA in the CARES Act (H.R. 748, S. 3548). Support the Coronavirus Health Care Worker Wellness Act (H.R. 7255) to help promote mental health wellness among physicians and other health care workers during the Public Health Emergency. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package (H.R. 8702/S. 5007, Holding Providers Harmless from Medicare Cuts During COVID-19 Act; S. 8505, a bill to provide a one-year waiver of budget neutrality adjustment under the Medicare Physician Fee Schedule; H.R. 133, Consolidated Appropriations Act, 2021). Support H.R. 7233, the KEEP Telehealth Options Act. Oppose H.R 884/S. 2772 the Medicare Mental Health Access Act

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 1959, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077/S. 2546, Safe Step Act. Support H.R. 1035, Prescription Drug Price Transparency Act. Support H.R. 985, Fair Access for Safe and Timely Generics Act. Support S. 476, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act. Support H.R. 1034/S. 640, Phair Pricing Act. Support S. 657, Drug Price Transparency Act Support H.R. 938, BLOCKING Act Support H.R. 2375/S. 64, Preserve Access to Affordable Generics & Biosimilars Act Support H.R. 1499, Protecting Consumer Access to Generic Drugs Act Support H.R. 2296/S. 1391, Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2069, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act. Support H.R. 2115, Public Disclosure of Drug Discounts Act Support H.R. 2376/S. 1227, Prescription Pricing for the People Act Support H.R. 1379/S. 560, Ensuring Lasting Smiles Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 3107, Improving Seniors Timely Access to Care Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Support S. 2443 Investment in Tomorrows Pediatric Health Care Workforce Act Support H.R. 1554, Resident Education Deferred Interest (REDI) Act. Advocate for the continued and increased funding of Community Health Centers. Lobby members of Congress to cosponsor H. Res. 323, which would support state, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and would express the sense of the House of Representatives that state, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. In the context of legislation to address surprise medical bills, advocate for an independent dispute resolution (IDR) process to resolve disputes between payers and physicians and against provisions that would set out-of-network reimbursement rates at a benchmark level. (H.R. 2328, H.R. 3502, S. 1531, S. 1895, H.R. 133) Support H.R. 4575, Improving Provider Directories Act, which would require group health plans and health insurance issuers offering group or individual health insurance coverage to establish a process to address inaccurate information listed in publicly accessible provider directories of such plans and issuers. Support the Creating Opportunities Now for Necessary and Effect Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/H.R. 4932), which would increase access to telehealth services. Support legislation to address drug shortages by providing additional authority to the Food and Drug Administration (FDA) to ensure a stable supply of medications (S. 2723, Mitigating Emergency Drug Shortages Act; H.R. 6080, Preventing Drug Shortages Act). Similar provisions to mitigate drug shortages included in CARES Act (H.R. 748, S. 3548). Request resources to provide personal protection equipment (PPE) and supplies and relief from Medicare payment sequester and relief from penalties in Merit-based Incentive Payment System (MIPS) under MACRA in the CARES Act (H.R. 748, S. 3548). Support the Coronavirus Health Care Worker Wellness Act (H.R. 7255) to help promote mental health wellness among physicians and other health care workers during the Public Health Emergency. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package (H.R. 8702/S. 5007, Holding Providers Harmless from Medicare Cuts During COVID-19 Act; S. 8505, a bill to provide a one-year waiver of budget neutrality adjustment under the Medicare Physician Fee Schedule; H.R. 133, Consolidated Appropriations Act, 2021). Support H.R. 7233, the KEEP Telehealth Options Act. Oppose H.R 884/S. 2772 the Medicare Mental Health Access Act

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and policies relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148) Reauthorization of funding for the Childrens Health Insurance Program Reauthorization of the Child Nutrition Act Section 2706 of the ACA regarding provider non-discrimination Policies related to health insurance market stabilization Policies affecting nurse practitioner education and workforce Definition, evaluation and enforcement of essential health benefits and provider network adequacy Health information technology and electronic health records Mental health services and violence prevention Human and child trafficking Palliative Care and Hospice Education and Training Act (H.R. 647/S. 2080) Title VIII Nursing Workforce Reauthorization Act of 2019 (H.R. 728/S. 1399) Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748/S.3548) Emergency Medical Services for Children Program Reauthorization Act of 2019 (H.R. 776/S. 1173) End Surprise Billing Act of 2019 (H.R. 861) Fairness for Breastfeeding Mothers Act (H.R. 866/S. 528) Heroes Act (H.R. 925) Mental Health Access Improvement Act of 2019 (H.R. 945) Mental Health Services for Students Act of 2019 (H.R. 1109) Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 1309) Competitive Health Insurance Reform Act of 2020 (H.R. 1418) Patient Protection and Affordable Care Enhancement Act (H.R. 1425) Healthy Families Act (H.R. 1784/S. 840) Mothers and Offspring Mortality and Morbidity Awareness (MOMMAs) Act (H.R. 1897) School-Based Health Centers Reauthorization Act of 2019 (H.R. 2075/S. 1013) Scarlett's Sunshine on Sudden Unexpected Death Act (H.R. 2271/S. 1130) Easy MAT for Opioid Addiction Act (H.R. 2281) Community Health Investment, Modernization, and Excellence Act of 2019 (H.R. 2328) Newborn Screening Saves Lives Reauthorization Act of 2019 (H.R. 2507) Pregnant Workers Fairness Act (H.R. 2694) Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act of 2019 (H.R. 2781) Vaccine Awareness Campaign to Champion Immunization Nationally and Enhance Safety (VACCINES) Act of 2019 (H.R. 2862) Physical Activities Recommendations for Americans Act of 2019 (H.R. 2891) Safe Cribs Act of 2019 (H.R. 3170) Safe Sleep for Babies Act of 2019 (H.R. 3172) Pathways to Health Careers Act (H.R. 3398) Chronic Care Management Improvement Act (H.R. 3436) No Surprises Act (H.R. 3630) Midwives for Maximizing Optimal Maternity Services (Midwives for MOMS) Act of 2019 (H.R. 3849) Social Determinants Accelerator Act of 2019 (H.R. 4004/S. 2986) Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019 (H.R. 3328/H.R. 4100/S. 1712) Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 (H.R. 4861/S. 3006) United States Public Health Service Modernization Act of 2019 (H.R. 4870/S. 2629) Medication Access and Training Expansion (MATE) Act of 2019 (H.R. 4974) Maternal Health Quality Improvement Act of 2019 (H.R. 4995) Helping Medicaid Offer Maternity Services (MOMS) Act of 2019 (H.R. 4996) Protecting Seniors Through Immunization Act of 2019 (H.R. 5076/S. 1872) Pursuing Equity in Mental Health Act of 2019 (H.R. 5469) Primary and Behavioral Health Care Access Act (H.R. 5575) Ban Surprise Billing Act (H.R. 5800) Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826) Black Maternal Health Momnibus Act of 2020 (H.R. 6142/S. 3424) Families First Coronavirus Response Act (H.R. 6201) Take Responsibility for Workers and Families Act (H.R. 6379) Health Care at Home Act (H.R. 6644) COVID-19 Mental Health Research Act (H.R. 6645) HEROES Act (H.R. 6800) Child Care Is Essential Act (H.R. 7027) Ensuring Children and Child Care Workers Are Safe Act of 2020 (H.R. 7079) Child Care for Economic Recovery Act (H.R. 7327) Protect Telehealth Access Act (H.R. 7391) Protecting Access to Post-COVID-19 Telehealth Act of 2020 (H.R. 7663) Community and Public Health Programs Extension Act (S. 192) National Nurse Act of 2019 (S. 696/H.R. 1597) Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767) Nursing Where It's Needed Act (S. 1045) Promoting Physical Activity for Americans Act (S. 1608) Lower Health Care Costs Act (S. 1895) National Suicide Hotline Designation Act (S. 2661) Child Care Protection Improvement Act of 2019 (S. 2683) CONNECT for Health Act of 2019(S. 2741/H.R. 4932) CAPTA Reauthorization Act of 2019 (S. 2971) Suicide Prevention Act (S. 3198/H.R. 5619) Eliminating Abusive and Rampant Neglect of Interactive Technologies (EARN IT) Act of 2020 (S. 3398) Tele-Mental Health Improvement Act (S. 3792) Coronavirus Mental Health and Addiction Assistance Act of 2020 (S. 3825/H.R. 6999) Mental and Behavioral Health Connectivity Act (S. 3999) Future Advancement of Academic Nursing (FAAN) Act (S. 4396/H.R. 7945) Safe Authorization for Vaccines during Emergencies (SAVE) Act (S. 4427) Pioneering Antimicrobial Subscriptions to End Up surging Resistance (PASTEUR) Act of 2020 (S. 4760)

Client expense: Not reported · Firm income: $24,000

Government targets: Bureau of Alcohol Tobacco Firearms & Explosives, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office

Lower Health Care Costs Act (S.1895) Reauthorizing and Extending America's Community Health Act - REACH Act (H.R. 2328) Preserve Access to Affordable Generics and Biosimilars Act (S. 64/H.R. 2375) Protecting Jessica Grubbs Legacy Act (S. 1012) Overdose Prevention and Patient Safety Act (H.R. 2062) ACA Medicaid disproportionate share hospital (DSH) cuts Prescription Drug Price Transparency Act (H.R.1035) Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R. 803) Short on Competition Act (S. 844) Resident Physician Shortage Act of 2019 (H.R. 1763/S. 348) FAST Generics Act (H.R. 985) The Protecting Consumer Access to Generic Drugs Act of 2019 (H.R. 1499) The Fair and Immediate Release of Generic Drugs Act (H.R. 1506) The Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 (H.R. 938) The Orange Book Transparency Act of 2019 (H.R. 1503) The Purple Book Continuity Act of 2019 (H.R. 1520) Home infusion: 50401 of the Bipartisan Budget Act of 2018 (BBA) (Pub. L. 115-123) and section 5012 of the 21st Century Cures Act of 2016 (CURES) (Pub. L. 114-255) Phair Pricing Act (H.R. 1030) Improving Seniors' Timely Access to Care Act of 2019 (H.R. 3107) The Mitigating Emergency Drug Shortages (MEDS) Act (S.2723) Accountable Care in Rural America Act (H.R. 5212) Rural ACO Improvement Act (S.2648) Helping Medicaid Offer Maternity Services (H.R. 4996) Prescription Drug Pricing Reduction Act of 2019 (S. 2543) Stop STALLING Act (H.R. 2374) Reforming Evergreening and Manipulation that Extends Drug Years Act (S. 1209) Preventing Drug Shortages Act (H.R. 6080) Protecting Jessica Grubb's Legacy Act (S. 3374) Preserving Patient Access to Home Infusion Act (H.R. 6218/S. 3457) Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) Families First Coronavirus Response Act (H.R. 6201) Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) The HEROES Act (HR 6800)

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discussions on drug pricing, 340b, and price transparency policies, as well as the International Pricing Index ANPRM; Discussions about the work of Aligning for Health to address social determinants of health; Support HR 1041 / S 586,Critical Access Hospital Relief Act of 2019, a bill to amend title XVIII of the Social Security Act to remove the 96-hour physician certification requirement for inpatient critical access hospital services; Support S 895, Rural Hospital Regulatory Relief Act of 2019, a bill to provide for a permanent extension of the enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals; Support S 948,Conrad State 30 and Physician Access Reauthorization Act, a bill to provide incentives to physicians to practice in rural and medically underserved communities, and for other purposes; Discussions in support of the Rural Emergency Medical Center Act (REACH) Act; Support for extension of the Rural Community Hospital Demonstration Program; Support for extension of the Frontier Community Health Integration Project Demonstration program; Discuss changes with House and Senate committees to Section 8122 of the SUPPORT for Patients and Communities Act; Letter of support to Energy and Commerce Committee for the hearing on legislation to strengthen our health care system and ACA market stability; Support HR 1781/ S 801, Payment Commission Data Act of 2019, a bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information; Support S 551 Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019, a bill to amend title XVIII of the Social Security Act to require manufacturers of certain single-dose vial drugs payable under part B of the Medicare program to provide rebates with respect to amounts of such drugs discarded, and for other purposes; Support S 824/ HR 1767, Excellence in Mental Health and Addiction Treatment Expansion Act, a bill to increase the number of States that may conduct Medicaid demonstration programs to improve access to community mental health services; Statement submitted to Senate Finance Committee on the implementation of the Quality Payment Program (QPP) created by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); Support HR 2552Protecting Local Access to Care for Everyone Act of 2019 or the PLACE Act of 2019, a bill to direct the Secretary of Health and Human Services to prevent certain payment reductions for clinic visit services furnished at excepted off-campus outpatient departments of a provider under the Medicare program; Support HR 3022, Patient Access Protection Act, a bill to amend title XIX of the Social Security Act to repeal the reductions in Medicaid DSH allotments, and for other purposes; Letter of support to the Ways and Means Committee in support of legislation to improve the quality of an access to services for Medicare beneficiaries, help train the physician workforce and reduce administrative burden on rural hospitals; Support HR 3431, HEARTS and Rural Relief Act, a bill to provide for the extension of the enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals through 2021; Support HR 3417,Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019 or the BETTER Act of 2019, a bill to amend title XVIII of the Social Security Act to provide for patient improvements and rural and quality improvements under the Medicare program; Oppose HR 1384, Medicare for All Act of 2019, a bill to establish an improved Medicare for All national health insurance program; Oppose S 1129, Medicare for All Act of 2019, a bill to establish a Medicare-for-all national health insurance program; Letter to House Committee on Ways and Means for the hearing on Pathways to Universal Health Coverage addressing concerns with Medicare for All and believe that the variety of proposals that often are used interchangeably under that name are not the solution; Oppose HR 2452, Medicare for America Act of 2019, a bill to amend the Social Security Act to establish a Medicare for America health program to provide for comprehensive health coverage for all Americans; Letter to House Committee on Budget for the hearing on the Congressional Budget Offices (CBO) Key Design Components and Considerations for Establishing a Single-Payer Health Care System addressing concerns with Medicare for All; Oppose S 1261/ HR 2463, Choose Medicare Act, a bill to provide for the establishment of Medicare part E public health plans, and for other purposes; Oppose S 981/ HR 2000Medicare-X Choice Act of 2019A bill to establish a public health plan; Oppose S 1033/ HR 2085, CHOICE Act, a bill to amend the Public Health Service Act to establish a public health insurance option, and for other purposes; Oppose S 470, Medicare at 50 Act, a bill to amend title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare; Oppose HR 1346, Medicare Buy-In and Health Care Stabilization Act of 2019, a bill to amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes; Submitted Statement to the House Committee on Rules for the Hearing Medicare for All Act of 2019; Comment on provisions of HR 2328,Reauthorizing and Extending Americas Community Health (REACH) Act, support for the Medicaid disproportionate share hospital(DSH) program provisions included in Title III; comments on Title IV, which contains provisions of the No Surprises Act and concern with the legislations approach to determining reimbursement for out-of-network providers; Support HR 3107 Seniors Timely Access to Care Act of 2019, this legislation would establish requirements for the use of prior authorization under Medicare Advantage plans; Meeting with the Senate finance committee to discuss changes to drug bill; Meeting with CMS to discuss changes to prior authorization; Meeting with Department of Labor to discuss issues with ERISA health plans; Met with CMS staff on rural hospital issues; Regulatory burden related to new CMS guidance on documenting Crossover bad debt; Sent a Comment letter to CMS on a final rule on program integrity enhancements to the provider enrollment process for Medicare, Medicaid and Children's Health Insurance Programs; Oppose S. 2860 Patient Access to Higher Quality Health Care Act of 2019, a bill to repeal changes made by health care reform laws to the Medicare exception to the prohibition on certain physician referrals for hospitals, and for other purposes; Support HR 4996, Helping MOMS Act of 2019, a bill amend title XIX of the Social Security Act to provide for a State option under the Medicaid program to provide for and extend continuous coverage for certain individuals, and for other purposes; Addressing hospital concerns about HR 3 Lower Drug Costs Now Act, a bill to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes; Sent comment letter requesting that CMS withdraw the proposed regulation related to Medicaid Program: Medicaid Fiscal Accountability Regulation ( MFAR) financing and supplemental payments. Given that the proposal would severely curtail the availability of health care services to millions of individuals and because many of its provisions are not legally permissible; Discussion with CMS for rural hospitals and critical access hospitals about the Medicare accelerated payment program, which is intended to provide necessary funds to providers, including rural hospitals and critical access hospitals, when there is a disruption in claims submission and/or claims processing; Submitted comments on CMSs proposed rule on Medicare Advantage and Part D prescription drug program for Contract Years 2021 and 2022. The letter focuses on several proposals addressing network adequacy; Letter sent to HHS, CDC, CMS, and SAMHSA requesting specialized guidance and assistance for providers who care for patients with behavioral health disorders; Support resetting the Improving Medicare Post- Acute Care Transformation (IMPACT) Act of 2014 in the next COVID-19 relief package. The IMPACT Acts implementation is behind schedule and does not take into account extensive payment reforms already underway in each post-acute care setting; Letter urging HHS to release substantial additional emergency funds to all hospitals in an expedited manner. This second wave of funding to all hospitals, targeted relief is necessary for hospitals in hot spots, hospitals with a high percentage of payments under Medicare Advantage, hospitals caring for high numbers of Medicaid patients, and rural hospitals; Support HR 6693 Critical Access Hospital Expansion Act of 2020, a bill to amend title XVIII of the Social Security Act to allow States to certify certain hospitals as necessary providers for purposes of designating such hospitals as critical access hospitals under the Medicare program; Support HR 6753/ S 3615 Rural Community Hospital Demonstration Extension Act of 2020, a bill to amend the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to extend the rural community hospital demonstration program; Letter urging CMS to use its authority to extend to LTCHs the existing 20% hospital add-on payment for Medicare beneficiaries diagnosed with COVID-19; Letter to CMS urging the agency to temporarily extend certain waivers and make others permanent beyond the COVID-19 public health emergency to allow hospitals to provide better and more cost effective care to their patients and communities; Sent comment letter to CMS about our concerns with the timeline proposed for implementation as well as the potential for penalties for noncompliance within this timeline on the Medicare Program: Electronic Prescribing of Controlled Substances; Sent comment letter on the FY 2021 Inpatient PPS proposed rule addressing CMS proposals related to payer-specific negotiated rate data collection, Medicare DSH payments, CAR T, bad debt, MS-DRG classifications, and quality programs, among other topics. Letter requesting that the CMS delay the implementation of the Appropriate Use Criteria for Advanced Diagnostic Imaging Services program to allow providers the opportunity to implement and test operational changes and acquire the education necessary to achieve compliance with the program; Sent comments to the CMS on the agencys long-term care hospital prospective payment system proposed policy changes and fiscal year 2021 rates; Letter to CMS asking for a delay in the start of repayments associated with the Medicare Accelerated and Advance Payment (AAP) Programs; Letter urging the CMS to continue its suspension of medical review activities throughout the ongoing COVID-19 public health emergency; Letter urging CMS to allow periodic interim payment (PIP) hospitals to carry out their accelerated payment repayment at cost settlement, as was initially communicated by the agency and also request that the agency make alternative repayment approaches available, such as direct payments to the Medicare Administrative Contractor (MAC), for all hospitals; Comment letter on CY 2021 Home Health Prospective Payment System Rate Update proposed rule. While we continue to support the PDGM objective of increasing HH PPS payment accuracy, we remain concerned that CY 2020s large behavioral offset, 4.36%, was implemented on a prospective basis; Letter urging the CMS to withdraw the condition of participation (CoP) that hospitals report daily COVID-19 data and request that CMS immediately release detailed interpretive guidance so hospitals can take the necessary steps to come into compliance; Urged CMS to withdraw its Medicaid fiscal accountability proposed rule from its regulatory agenda because it would "severely curtail the availability of health care services to millions of individuals" and "many of its provisions are not legally permissible;" Submitted comment letter that disagree with CMS interim APC assignments of COVID-19 vaccine administration services to these New Technology APCs because they are inconsistent with longstanding CMS policy; Submitted comments responding to a CMS request for information on regulatory relief to support economic recovery urging the agency to take additional action to remove certain regulatory barriers standing in the way of efficiency and innovation, thus allowing hospitals to provide better and more cost-effective care to our patients and communities. In order to achieve these objectives, we ask the agency to temporarily extend certain waivers and make others permanent beyond the duration of the COVID-19 public health emergency; Urged a delay implementation of CMS price transparency rule and also asked the Biden Transition team for enforcement discretion with the rule; Letter urging Congress to include in the year-end legislation an extension of the congressionally-enacted moratorium on the application of the Medicare sequester cuts into 2021 and through the duration of the public health emergency (PHE); Letter urging Congress to continue to support the movement to value by ensuring that clinicians in advanced alternative payment models (APMs) continue to receive incentives established under the bipartisan Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); Support S 5044, The Improving Seniors Timely Access to Care Act of 2020, a bill to amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans; Submitted a comment letter, urging CMS not to finalize proposals that would allow states to create a new type of direct enrollment marketplace in lieu of Healthcare.gov or a state-based marketplace. In addition, we do not support the codification in regulation of previous Section 1332 guidance that could allow states to pursue alternative approaches to coverage that would result in coverage losses; Support efforts to protect patients from surprise medical bills by including the No Surprises Act as part of the year-end legislative package; Submitted COVID-19 snapshot report for Congress to better understand the needs of hospitals and health systems during the public health emergency, which combines important data points with news articles and testimonials from the field to reiterate the dire circumstances hospitals and health systems face, and highlight why additional relief is necessary; Submitted comments in response to HRSAs proposal to include additional counties as eligible to receive Federal Office of Rural Health Policy (FORHP) grants, encouraged the agency to use a definition of rural that is inclusive and flexible, in order to broaden opportunities for providers in rural communities and urged HRSA to increase rural grant opportunities.

Client expense: $4,460,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office

-Issues related to H.R. 6644 / S. 3741, to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for services furnished via telehealth if such services would be covered if furnished in-person during the COVID-19 emergency -Issues related to H.R. 6800 / H.R. 925 the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act). -Issues related to H.R. 6810, the Health Care Protection Act, and H.R. 6514, the Worker Health Coverage Protection Act, and S. 4329, the Continuous Health Coverage for Workers Act. -Issues related to H.R. 861, the End Surprise Billing Act; H.R. 3502, The Protecting People from Surprise Medical Bills Act; H.R.2328, Community Health Investment, Modernization, and Excellence Act of 2019 and H.R. 3630, The No Surprises Act, and H.R. 5800, The Ban Surprise Billing Act. -Issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, Families First Coronavirus Response Act. P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act). HR 6379, Take Responsibility for Workers and Families Act. -Issues related to S. 1895, the Lower Health Care Costs Act, including: surprise billing, and transparency and information sharing in the individual and commercial markets. -Issues related to the drug and medical device supply chain concerns related to the coronavirus response efforts. -Issues relating to P.L. 111-148, the Patient Protection and Affordable Care Act and P.L. 111-152, the Health Care and Education Reconciliation Act, including exchanges, cost sharing reduction, market reforms and coverage expansion proposals, stand-alone dental plans, and non-discrimination provisions. -June 24, 2019 Executive Order, "Improving Price and Quality Transparency in American Healthcare to Put Patients First" -July 24, 2020 Executive Orders that direct federal agencies to prioritize policies that would: (1) permit drug importation from Canada and other countries, and specifically authorizes the re-importation of insulin products; (2) ensure that prices charged to low-income uninsured patients for insulin and epinephrine at Federally Qualified Health Centers (FQHCs are federally subsidized clinics that commonly participate in the 340B drug pricing program) align with the costs at which the FQHC acquired the drugs; (3) ban drug rebates in Medicare that are not passed at the point of sale; and (4) advance a most favored nation (MFN) rule to lower Medicare drug payments to prices similar to what other countries pay. -Issues related to H.R. 6561/S. 4440 - Improving Social Determinants of Health Act of 2020 and H.R. 4004/ S. 2986, the Social Determinants Accelerator Act of 2019. -Issues related to H.R. 7839 Continuing Access to In Home Intravenous Immunoglobulin (IVIG) Act. -Issues related to H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.

Client expense: $1,520,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health issues specifically related to group purchasing organizations, including matters related to supply chains in health care, including drugs and medical devices, drug pricing, and drug shortages. Issues related to FDA listening sessions and public meeting on drug shortages Issues related to tariffs on critical healthcare supplies Issues related to incentivizing domestic manufacturing of critical healthcare supplies S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 H.R. 2328, Reauthorizing and Extending America's Community Health Act H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act COVID-19 response legislation. S. 3780, The Help Onshore Manufacturing Efficiencies for Drugs and Devices Act (HOME Act) of 2020 S. 3781, The Pharmaceutical Accountability Responsibility and Transparency (PART) Act of 2020

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Health issues specifically related to group purchasing organizations, including matters related to supply chains in health care, including drugs and medical devices, drug pricing, and drug shortages. Shortages of CII injectable narcotics Issues related to FDA listening sessions and public meeting on drug shortages Issues related to tariffs on critical healthcare supplies Issues related to incentivizing domestic manufacturing of critical healthcare supplies S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 H.R. 2328, Reauthorizing and Extending America's Community Health Act H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act COVID-19 response legislation. S. 3780, The Help Onshore Manufacturing Efficiencies for Drugs and Devices Act (HOME Act) of 2020 S. 3781, The Pharmaceutical Accountability Responsibility and Transparency (PART) Act of 2020

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to legislative proposals that impact the health insurance market. Medicare Advantage issues. Legislative proposals on Surprise Balance Billing, including: H.R. 2328, the Community Health Investment, Modernization, and Excellence Act of 2019; H.R. 5800, the Ban Surprise Billing Act; H.R. 5826, the Consumer Protections Against Surprise Medical Bills Act of 2020; S. 1895, the Lower Health Care Costs Act; and H.R. 133, Consolidated Appropriations Act, 2021.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitor issues related to H.R. 861, the End Surprise Billing Act; H.R. 3502, the Protecting People from Surprise Medical Bills Act; H.R. 2328, the Community Health Investment, Modernization, and Excellence Act of 2019; H.R. 3630, the No Surprises Act; and H.R. 5800, the Ban Surprise Billing Act; issues related to P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Families First Coronavirus Response Act; P.L. 116-136, the Coronavirus Aid, Response, and Economic Security Act (CARES Act); issues related to S. 1895, the Lower Health Care Costs Act, including: surprise billing and transparency and information sharing in the individual and commercial markets; issues related to H.R. 6644 / S. 3741, to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for services furnished via telehealth if such services would be covered if furnished in-person during the COVID-19 emergency; issues related to H.R. 7839 Continuing Access to In Home Intravenous Immunoglobulin (IVIG) Act; issues related to H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1895 - Lower Health Care Costs Act H.R. 2668 - Special Diabetes Program Reauthorization Act of 2019 H.R. 2680 - Special Diabetes Program for Indians Reauthorization Act of 2019 S. 3937 - Special Diabetes Program for Indians Reauthorization Act of 2020 H.R. 2328 - Reauthorizing and Extending Americas Community Health Act (REACH Act) S. 2543 - The Prescription Drug Pricing Reduction Act of 2019 S. 2199, H.R. 4906 - Insulin Price Reduction Act S. 2004, H.R. 4010 -- Emergency Access to Insulin Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 H.R. 5749 - Affordable Insulin for All Act S. 2855, H.R. 5691 - Insulin Affordability Data Collection Act H.R. 19, S. 3129 - Lower Costs, More Cures Act of 2019 Issues and legislation related to drug pricing, specifically as it relates to insulin. Issues and legislation related to a passthrough of any/all savings to beneficiaries using insulin in Medicare Part D. Issues and legislation related to providing flexibility in the split of a deductible between devices and prescription drugs. Issues related to the importance of preserving health insurance protections for individuals with pre-existing conditions. Issues related to providing (during the COVID-19 emergency period) and preserving (after the COVID-19 emergency period) telehealth/telemedicine flexibilities for individuals with type 1 diabetes. S. 4315/H.R. 6666 - COVID-19 Testing, Reaching, And Contacting Everyone Act (TRACE) Act H.R. 3630 - No Surprises Act

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Health care reform including implementation of the Affordable Care Act; and a comprehensive approach to surprise medical billing/ensuring patients are not held responsible, including advocacy related to: H.R. 3502, the Protecting People From Surprise Medical Bills Act; H.R. 3630, the No Surprises Act; S. 1531, the STOP Surprise Medical Bills Act; S. 1895, the Lower Health Care Costs Act, and H.R. 2328, the REACH Act, H.R. 2328, the REACH Act; and H.R. 133, the Consolidated Appropriations Act, 2021 - P.L. 116-260. Coronavirus response efforts, including support for health care providers, patients and small business, and related provisions in H.R. 6800, the HEROES Act; H.R. 8406, the Heroes Act; S. 4318, the American Workers, Families, and Employers Assistance Act; S. 4320, the Coronavirus Response Additional Supplemental Appropriations Act, 2020; and S. 4322, the Safely Back to School and Back to Work Act; related provisions in Sec. 2501 of H.R. 8337, the Continuing Appropriations Act, 2021 and Other Extensions Act re: modifications to the Accelerated and Advance Payment Programs; and H.R. 133, the Consolidated Appropriations Act, 2021 - P.L. 116-260.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 1959, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077/S. 2546, Safe Step Act. Support H.R. 1035, Prescription Drug Price Transparency Act. Support H.R. 985, Fair Access for Safe and Timely Generics Act. Support S. 476, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act. Support H.R. 1034/S. 640, Phair Pricing Act. Support S. 657, Drug Price Transparency Act Support H.R. 938, BLOCKING Act Support H.R. 2375/S. 64, Preserve Access to Affordable Generics & Biosimilars Act Support H.R. 1499, Protecting Consumer Access to Generic Drugs Act Support H.R. 2296/S. 1391, Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2069, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act. Support H.R. 2115, Public Disclosure of Drug Discounts Act Support H.R. 2376/S. 1227, Prescription Pricing for the People Act Support H.R. 1379/S. 560, Ensuring Lasting Smiles Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 3107, Improving Seniors Timely Access to Care Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Support S. 2443 Investment in Tomorrows Pediatric Health Care Workforce Act Support H.R. 1554, Resident Education Deferred Interest (REDI) Act. Advocate for the continued and increased funding of Community Health Centers. Lobby members of Congress to cosponsor H. Res. 323, which would support state, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and would express the sense of the House of Representatives that state, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. In the context of legislation to address surprise medical bills, advocate for an independent dispute resolution (IDR) process to resolve disputes between payers and physicians and against provisions that would set out-of-network reimbursement rates at a benchmark level. (H.R. 2328, H.R. 3502, S. 1531, S. 1895, H.R. 133) Support H.R. 4575, Improving Provider Directories Act, which would require group health plans and health insurance issuers offering group or individual health insurance coverage to establish a process to address inaccurate information listed in publicly accessible provider directories of such plans and issuers. Support the Creating Opportunities Now for Necessary and Effect Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/H.R. 4932), which would increase access to telehealth services. Support legislation to address drug shortages by providing additional authority to the Food and Drug Administration (FDA) to ensure a stable supply of medications (S. 2723, Mitigating Emergency Drug Shortages Act; H.R. 6080, Preventing Drug Shortages Act). Similar provisions to mitigate drug shortages included in CARES Act (H.R. 748, S. 3548). Request resources to provide personal protection equipment (PPE) and supplies and relief from Medicare payment sequester and relief from penalties in Merit-based Incentive Payment System (MIPS) under MACRA in the CARES Act (H.R. 748, S. 3548). Support the Coronavirus Health Care Worker Wellness Act (H.R. 7255) to help promote mental health wellness among physicians and other health care workers during the Public Health Emergency. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package (H.R. 8702/S. 5007, Holding Providers Harmless from Medicare Cuts During COVID-19 Act; S. 8505, a bill to provide a one-year waiver of budget neutrality adjustment under the Medicare Physician Fee Schedule; H.R. 133, Consolidated Appropriations Act, 2021). Support H.R. 7233, the KEEP Telehealth Options Act. Oppose H.R 884/S. 2772 the Medicare Mental Health Access Act

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobby members of Congress regarding issues related to telemedicine. Advocate for increased transparency regarding drug pricing. Lobby members of the House to join the Congressional Skin Cancer Caucus. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Support H.R. 1959, Preserving Patient Access to Compounded Medications Act. Support H.R. 2077/S. 2546, Safe Step Act. Support H.R. 1035, Prescription Drug Price Transparency Act. Support H.R. 985, Fair Access for Safe and Timely Generics Act. Support S. 476, C-THRU Act. Support S. 989, Ensuring Childrens Access to Specialty Care Act. Support H.R. 1034/S. 640, Phair Pricing Act. Support S. 657, Drug Price Transparency Act Support H.R. 938, BLOCKING Act Support H.R. 2375/S. 64, Preserve Access to Affordable Generics & Biosimilars Act Support H.R. 1499, Protecting Consumer Access to Generic Drugs Act Support H.R. 2296/S. 1391, Fair Accountability & Innovative Research (FAIR) Drug Pricing Act Support H.R. 2069, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act. Support H.R. 2115, Public Disclosure of Drug Discounts Act Support H.R. 2376/S. 1227, Prescription Pricing for the People Act Support H.R. 1379/S. 560, Ensuring Lasting Smiles Act. Advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Support H.R. 3107, Improving Seniors Timely Access to Care Act Support pediatric subspecialty loan repayment in any reauthorization of the Title VII programs. Support S. 2443 Investment in Tomorrows Pediatric Health Care Workforce Act Support H.R. 1554, Resident Education Deferred Interest (REDI) Act. Advocate for the continued and increased funding of Community Health Centers. Lobby members of Congress to cosponsor H. Res. 323, which would support state, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and would express the sense of the House of Representatives that state, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection. In the context of legislation to address surprise medical bills, advocate for an independent dispute resolution (IDR) process to resolve disputes between payers and physicians and against provisions that would set out-of-network reimbursement rates at a benchmark level. (H.R. 2328, H.R. 3502, S. 1531, S. 1895, H.R. 133) Support H.R. 4575, Improving Provider Directories Act, which would require group health plans and health insurance issuers offering group or individual health insurance coverage to establish a process to address inaccurate information listed in publicly accessible provider directories of such plans and issuers. Support the Creating Opportunities Now for Necessary and Effect Care Technologies (CONNECT) for Health Act of 2019 (S. 2741/H.R. 4932), which would increase access to telehealth services. Support legislation to address drug shortages by providing additional authority to the Food and Drug Administration (FDA) to ensure a stable supply of medications (S. 2723, Mitigating Emergency Drug Shortages Act; H.R. 6080, Preventing Drug Shortages Act). Similar provisions to mitigate drug shortages included in CARES Act (H.R. 748, S. 3548). Request resources to provide personal protection equipment (PPE) and supplies and relief from Medicare payment sequester and relief from penalties in Merit-based Incentive Payment System (MIPS) under MACRA in the CARES Act (H.R. 748, S. 3548). Support the Coronavirus Health Care Worker Wellness Act (H.R. 7255) to help promote mental health wellness among physicians and other health care workers during the Public Health Emergency. Advocate for congressional action to hold health care professionals harmless from any cuts related to CMS Evaluation and Management Code proposals in any forthcoming legislative package (H.R. 8702/S. 5007, Holding Providers Harmless from Medicare Cuts During COVID-19 Act; S. 8505, a bill to provide a one-year waiver of budget neutrality adjustment under the Medicare Physician Fee Schedule; H.R. 133, Consolidated Appropriations Act, 2021). Support H.R. 7233, the KEEP Telehealth Options Act. Oppose H.R 884/S. 2772 the Medicare Mental Health Access Act

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to Medicaid reform, block grant proposals, per capita caps Medicare and Medicaid Graduate Medical Education Medicare bad debt payments Medicaid waivers Medicaid Expansion Issues Medicaid Disproportionate Share Hospital Payments Medicare Disproportionate Share Hospital Payments Legislation related to chronic care treatment Medicaid supplemental payments to hospitals Medicare site neutral payments for hospitals outpatient departments Legislation related to healthcare disparities Medicaid State Flexibility Medicaid 1115 & 1332 Waivers Upper Payment Limit payments State Financing of Medicaid Medicare Part B Cuts-OPPS proposed rule to 340B covered entities Hospital Price Transparency National Quality Forum Funding Medicaid & CHIP Coverage Medicaid Funding for Certified Community Behavioral Health Centers Medicaid Funding for Community-Based long-term care H.R.2328 - REACH Act H.R.3414 - Opioid Workforce Act of 2019 S.1699 - Prescription Drug Cost Reduction Act H.R.3 - Lower Drug Costs Now Act of 2019 S.348 - Resident Physician Shortage Reduction Act of 2019 H.R.1763 - Resident Physician Shortage Reduction Act of 2019 S.2648 - The Rural ACO Improvement Act H.R.4496 - Helping Medicaid Offer Maternity Services Act of 2019 S.2741 - Creating Opportunities Now for Necessary and Efficient Care Technologies for Health Act of 2019 Medicaid Fiscal Accountability Regulation H.R 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 6201, Families First Coronavirus Response Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act H.R. 6379, Take Responsibility for Workers and Families Act H.R. 3, Elijah Cummings Lower Drug Costs Now Act H.R. 19, Lower Costs, More Cures Act S. 2543, Drug Pricing Reduction Act Social Determinants for Moms Act (H.R. 6132) IMPACT to Save Moms Act (H.R. 6137) Moms MATTER Act (H.R. 6143) Perinatal Workforce Act (H.R. 6164) Black Maternal Health Momnibus Act (S. 3424) Data to Save Moms Act (H.R. 6165) Social determinants of health HEROES Act Coronavirus Medicaid Response Act Federal Medical Assistance Percentage Telehealth Medicare Accelerated and Advance Payment Program H.R. 7663 - Protecting Access to Post-COVID-19 Telehealth Act of 2020 H.R.7791 - Value in Health Care Act of 2020 HR 4996, Helping MOMS Act Medicare Sequester COVID Moratorium Act (H.R. 8840) Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act (S. 1323) Supporting Best Practices for Healthy Moms Act (H.R. 8958/S.4949) Consolidated Appropriations Act, 2021 (H.R. 133) Medicare physician payment

Client expense: $370,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Repeal of the Affordable Care Act Development of legislation to protect essential hospitals Issues related to telehealth Mental Health Essential Health Benefits created by the Affordable Care Act Access to hospital emergency services Issues related to the 340B Drug Pricing Program 340B dug pricing program CMS OPPS 340B rule moratorium-related legislation 42 CFR Part 2 CREATES Act-H.R.965 Cassidy Surprise Billing Draft Protecting Patients from Surprise Medical Bills Excellence in Metal Health Act (S.824/H.R.1767) Patient Centered Outcomes Research Institute Funding No Surprises Act Lower Health Care Costs Act Surprise Medical Bills H.R.4004 - Social Determinants Accelerator Act of 2019 S.2986 - Social Determinants Accelerator Act of 2019 H.R.2328 - Reauthorizing and Extending America's Community Health Act S.2723 - Mitigating Emergency Drug Shortages Act H.R.4995 - Maternal Health Quality Improvement Act of 2019 H.R.2889 - Closing Loopholes for Orphan Drugs Act 340B drug pricing program eligibility (Matsui-Stewart Dear Colleague letter) Relief for Rural Providers During Emergencies Act (S. 3631) Improving Social Determinants of Health Act (H.R. 6561) Liability reform Issues related to COVID-19 regulatory and financial relief COVID-19 Provider Relief Fund Resolution recognizing racism as public health issue - S. Res. 655 COVID-19 Bias and Anti-Racism Training Act - S. 4248 Protecting 340B eligibility during the pandemic - S. 4160 and HR 7838 Protect Telehealth Access Act of 2020 (HR 7391) Improving Social Determinants of Health Act - S. 4440 Maternal health 340B contract pharmacies (McKinley-DeGette-Gianforte-Matsui-Johnson-Welch Dear Colleague letter) 340B contract pharmacies (Baldwin-Capito-Cardin-Portman-Stabenow-Thune Dear Colleague letter) Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act Health disparities COVID-19 payroll tax credits 340B rebate Dear Colleague letter (Spanberger-McKinley-Axne-Johnson-Matsui-Katko)

Client expense: $370,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 133, Consolidated Appropriations Act of 2021, including provisions relating to No Surprises Act, COVID-19 provisions (FMAP), health extenders (Money Follows the Person, Medicaid spousal impoverishment protections, IAH), prescription drug issues, and PBMs H.R. 925, The Heroes Act, including provisions related to House Amendment to the Senate Amendments updated Heroes Act; specifically provisions related to provisions related to access to healthcare including FMAP, testing, protections for public health workers, and benefits to children and families impacted by the coronavirus, Federal Medical Assistance Percentages (FMAP) H.R. 2328, Community Health Investment, Modernization, and Excellence Act of 2019, including provisions relating to Title IV surprise billing provisions H.R. 3630, No Surprises Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, including provisions relating to Marketplace, Commercial market issues S. 1895, Lower Health Care Costs Act, including issues relating to surprise billing, prescription drug costs, transparency, interoperability S. 3013, Encouraging Innovative Benefit Design to Lower Costs for Seniors Act, including provisions relating to prescription drug plans under Medicare Part D (allows for additional drug plan offerings) Potential legislation titled Health, Education Assistance, Liability Protections, Schools Act (HEALS Act) including provisions relating to commercial market and surprise billing Issues related to, ACA marketplace stabilization

Client expense: $910,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid program reforms, including telemedicine and Medicaid Fiscal Accountability Regulation Implementation of health care reform Section 340B Drug Pricing program Healthcare disparities issues generally Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices Implementation of electronic health records regulations generally Telemedicine policy generally, including FCC grant program for telehealth H.R. 5900 (Accelerating Kids' Access to Care Act), all provisions H.R. 7663 (Protecting Access to Post-COVID-19 Telehealth Act of 2020), all provisions S. 4108 (Coronavirus Medicaid Response Act), all provisions Mental health legislation generally

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including telemedicine and Medicaid Fiscal Accountability Regulation Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions Organ transplant policy generally, including liver transplant distribution methodology S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices Implementation of Children's Hospital Graduate Medical Education program

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2328 and S 192 and HR 1983, S 1895 To reauthorize and extend funding for Community Health Centers, Teaching Health Centers and the National Health Service Corps. COVID 19 funding to provide testing and build capacity for treatment, access to provider protective equipment, CARES Act implementation, Coronavirus Preparedness and Response Act, Families First Coronavirus Response Act, HR 6800 the HEROES Act. HEALS Act, Reimbursement for telehealth services. Administrative action to provide access to affordable health care treatments and services, HR 133 the Consolidated Appropriations Act

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

Issues regarding access to dental services. S. 1895, Lower Health Care Costs Act of 2019, H.R. 2328, Reauthorizing and Extending Americas Community Health Act and issues regarding surprise billing and exempt benefits. H.R. 3630, No Surprises Act. Monitored issues related to Indian Health Services. Monitored issues related to H.R. 5800, Ban Surprise Billing Act. H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; issues involving implementation of P.L. 116-136, Coronavirus Aid, Response, and Economic Security Act (CARES Act), as it relates to the provider relief fund; issues involving H.R. 925 / H.R. 8406, The HEROES Act and The Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; H.R. 1379, Ensuring Lasting Smiles Act. H.R. 133, Consolidated Appropriations Act of 2021, as it relates to surprise billing, the provider relief fund, testing, tracing and vaccines. Issues concerning provider relief fund disbursements.

Client expense: Not reported · Firm income: $60,000

Government targets: Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act, H.R.133 Consolidated Appropriations Act, 2021, H.R.8900 Further Continuing Appropriations Act, 2021, and Other Extensions Act, H.R.1520 Further Extension of Continuing Appropriations Act, 2021, H.R. 925 Updated Heroes Act, H.R.8496 SPEEDY COVID-19 Tests Act, S.4198 Affordable Coronavirus Testing Act, S.4740 Public Health Infrastructure Saves Lives Act, H.R.8505 To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes., H.R.8702 Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020.

Client expense: $450,946 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act, H.R.133 Consolidated Appropriations Act, 2021, H.R.8900 Further Continuing Appropriations Act, 2021, and Other Extensions Act, H.R.1520 Further Extension of Continuing Appropriations Act, 2021, H.R. 925 Updated Heroes Act, H.R.8496 SPEEDY COVID-19 Tests Act, S.4198 Affordable Coronavirus Testing Act, S.4740 Public Health Infrastructure Saves Lives Act, H.R.8505 To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes., H.R.8702 Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020.

Client expense: $450,946 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

surprise billing issues relating to clinical laboratory and ancillary providers, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019.COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act, H.R.133 Consolidated Appropriations Act, 2021, H.R.8900 Further Continuing Appropriations Act, 2021, and Other Extensions Act, H.R.1520 Further Extension of Continuing Appropriations Act, 2021, H.R. 925 Updated Heroes Act, H.R.8496 SPEEDY COVID-19 Tests Act, S.4198 Affordable Coronavirus Testing Act, S.4740 Public Health Infrastructure Saves Lives Act, H.R.8505 To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes., H.R.8702 Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020.

Client expense: $450,946 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

regulation and oversight of clinical laboratories, including laboratory developed test services and pharmacogenetic testing, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories, surprise billing issues relating to clinical laboratory and ancillary providers. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services; SUPPORT for Patients and Communities Act (PL 115-271), H.R. 3584/S. 3049 Laboratory Access for Beneficiaries Act, H.R. 3630 No Surprises Act, S. 1895 Lower Health Care Costs Act, S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1266 Protecting Patients from Surprise Medical Bills Act, H.R. 3502 Protecting People from Surprise Medical Bills Act, H.R. 861 End Surprise Billing Act of 2019, H.R. 2328 Reauthorizing and Extending Americas Community Health Act, H.R. 3107 Improving Seniors' Timely Access to Care Act of 2019, H.R. 2143 Promoting Integrity in Medicare Act of 2019, H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, H.R. 3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020, H.R. 2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020, H.R. 4378 Continuing Appropriations Act, 2020, and Health Extenders Act, H.R. 3055 Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, H.R. 1158 Consolidated Appropriations Act, 2020, H.R. 1865 Further Consolidated Appropriations Act, 2020. COVID-19 Pandemic Crisis Response, including COVID-19 laboratory capacity and testing, PL 116-123 Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, PL 116-127 Families First Coronavirus Response Act, PL 116-136 Coronavirus AID, Relief, and Economic Security Act (CARES Act/H.R. 748/S.3548), PL 116-139 Paycheck Protection Program and Health Care Enhancement Act, H.R.6800 - Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R.6585 - Equitable Data Collection and Disclosure on COVID-19 Act, S.3850 - Equitable Data Collection and Disclosure on COVID-19 Act, S.4198 - A bill to require health plans to provide coverage for COVID-19 serology testing, H.R.7667 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021, H.R.7610 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021, H.R.7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021, H.R.7615 - To provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, H.R.7658 - To provide a payroll tax credit for certain costs of providing employees with testing for COVID-19, S.4214 - A bill to provide a payroll tax credit for certain expenses associated with protecting employees from COVID-19, S.4198 - Affordable Coronavirus Testing Act, H.R. 925 - Updated Heroes Act, S.178 - Uighur Intervention and Global Humanitarian Unified Response Act of 2019, S.4318 - American Workers, Families, and Employers Assistance Act, S.4322 - Safely Back to School and Back to Work Act, S.4740 - Public Health Infrastructure Saves Lives Act, H.R.8337 - Continuing Appropriations Act, 2021 and Other Extensions Act, H.R.133 Consolidated Appropriations Act, 2021, H.R.8900 Further Continuing Appropriations Act, 2021, and Other Extensions Act, H.R.1520 Further Extension of Continuing Appropriations Act, 2021.

Client expense: $450,946 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to surprise emergency medical bills, including provisions in: S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act; S. 1895, the Lower Health Care Costs Act; H.R. 3630, the No Surprises Act; H.R. 2328, the Reauthorizing and Extending Americas Community Health Act; H.R. 3502, the Protecting People From Surprise Medical Bills Act; P.L. 116-260, the Consolidated Appropriations Act, 2021. Issues related to the proposed Conversion Factor reduction resulting from policy changes in Evaluation and Management codes in CY 2021 Physician Fee Schedule Proposed Rule (85 FR 50074) and CY 2021 Physician Fee Schedule Final Rule (85 FR 84472).

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Urged Congress to extend the moratorium on looming automatic 2% cuts (sequestration) in the Medicare program and $4 billion cuts in the Medicaid Disproportionate Share Hospital (DSH) program the duration of the public health emergency and at least until the end of 2021 to ensure providers have the resources to continue to care for patients and communities during this pandemic. Urged Congress to include language in the Continuing Resolution (CR) that eliminates the Medicaid Disproportionate Share Hospital (DSH) reductions slated to begin on December 1 of this year. Urged the House to support H.R. 2477, the Beneficiary Enrollment Notification an Eligibility Simplification (BENES) Act of 2019 which would modernize and simplify the Medicare Part B enrollment process as recommended by the Medicare Payment Advisory Commission (MedPAC). Urged the House to support H.R. 3935, the Protecting Patients Transportation to Care Act which would amend the Medicaid statute to include non-emergency medical transportation (NEMT) in the list of mandatory Medicaid benefits by codifying current Medicaid NEMT regulations. Urged the House to support H.R. 5201, the Tele-Mental Health Expansion Act of 2019 would permanently include a patients home as an eligible originating site for mental health services delivered via telehealth in the Medicare program. Urged Congress to increase the FMAP for Medicaid by 5.8 percent for a total increase of 12 percent to ensure states capacity to provide access to care though Medicaid in then next round of financial relief. Urged HHS to ensure that a proportional amount of the remaining Public Health and Social Services Emergency Fund (PHSSEF) and any additional relief funding appropriated by Congress, is provided quickly to ALL Medicaid providers and health professionals impacted by the COVID-19 pandemic. Urged the House to support the H.R. 826, Expressing disapproval of the Trump administrations harmful actions towards Medicaid. This resolution seeks to reverse the recent guidance from the Centers for Medicare and Medicaid Services (CMS) titled Healthy Adult Opportunity, which would essentially cap or block grant funding for certain populations. CMS-2393-P Medicaid Program; Medicaid Fiscal Accountability Regulation; Proposed Rule (84 Federal Register 63722, November 18, 2019) - Urged CMS not to finalize the proposed MFAR. The proposed rule could force states to reduce the size of their Medicaid programs by covering fewer beneficiaries, restricting health care services or reducing provider payment rates. Urged the House to support H.R. 3, the Lower Drug Costs Act Now of 2019, which includes proposals to lower the costs of prescription drugs through Medicare negotiation authority and also includes new Medicare protections and additional coverage. Urged the House to support H.R. 4650, the Medicare Dental Act of 2019, which would add a dental benefit to Medicare Part B. Urged the House to support H.R. 4665, the Medicare Vision Act of 2019, which would a vision benefit to Medicare Part B. Urged the House to support H.R. 4618, the Medicare Hearing Act of 2019, which would add a hearing benefit to Part B including hearing aids. 2393-P - Request for Extension of Comment Period for Medicaid Program; Medicaid Fiscal Accountability Regulation, 84 Fed. Reg. 63722 (November 18, 2019) - Urged CMS to extend the comment period on the proposed rule for at least 60 days, until March 17, 2020, to ensure that states and other stakeholders have sufficient time to provide CMS with the information it needs to make sound policy decisions. Territories Health Care Improvement Act (HR 3631) - Urged the Senate to adopt new funding levels for Medicaid in the Territories to address outdated funding mechanisms and matching rates. Urged the House and Senate to delay FY2020 funding cuts to Medicaid disproportionate share hospitals. Beneficiary Education Tools, Telehealth, and Extenders Re-authorization Act of 2019 (H.R. 3417) - Supported expanding mental and behavioral health telemedicine services to Medicare beneficiaries. Patient Centered Outcomes Research Institute (H.R. 3439) - Supported extending the legislation to provide research on substance use disorders, mental health, and maternal morbidity and mortality. The HEARTS and Rural Relief Act (H.R. 3429) - Supported extending the rural and critical access hospital moratorium for two years on direct supervision requirements for outpatient therapeutic services. Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019 (H.R. 3253) - Supported extending Medicaid demonstration programs to improve person-centered health care across the continuum of care. Maternal Health Quality Improvement Act (H.R. 4995) and Helping Medicaid Offer Maternity Services Act of (H.R. 4996) - Urged the Senate to pass both to help to eliminate preventable pregnancy-related deaths and improve maternal health outcomes. Reauthorizing and Extending America's Community Health (REACH) Act (H.R. 2328) - Opposed a statutory payment rate. Supported elimination of DSH funding cuts for FY 2020 and 2021. Supported permanent Medicaid funding in the United States territories. Supported demonstrations for Medicare beneficiaries that promote enrollment, education, and outreach.

Client expense: $196,341 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, President of the U.S., SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

Appropriations for health centers and related programs; Appropriations for National Health Service Corps; Appropriations for Health Professions Programs; Appropriations for the CDC and HRSA; Presidents Budget Request; CHIME(H.R.2328/S.106); Community and Public Health Extensions Act (S.192); Community Health Center and Primary Care Workforce Expansion Act (S.962/H.R.1943); School Based Health Centers Reauthorization (H.R.2075/S.1013); Lower Health Care Costs Act (S.1895); Extension of Continuing Appropriations Act of 2021(H.J.Res.110).

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office

S. 4840 Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 HR 133 The Consolidated Appropriations Act HR 6800 the HEROES Act re COVID relief S. 4163 re COVID Testing (Gardner) S. 4329 Continuous Health Coverage for Workers Act (McSally) HR 7472 re contract tracing (Speier) S. 4230 Telehealth Expansion Act (Wyden) HR 6395, National Defense Authorization Act S. 4049, National Defense Authorization Act HR 6666, COVID 19 Testing, Reaching and Contacting Everyone Act (TRACE Act) HR 1425, Patient Protection and Affordable Care Enhancement Act HR 6514, Worker Health Coverage Protection Act HR 6568, Coverage for COVID 19 Treatment Act HR 5438, Cox, The End Valley Fever Now Act S. 2897, Warner, regarding the reauthorization of PCORI HR 5201, Matsui, regarding telehealth and behavioral health HR 2328, the No Surprises Act S. 1895, the Lower Health Care Costs Act HR 987 and S. 455, regarding outreach and education activities under the ACA HR 3439, regarding the reauthorization of PCORI House Resolution 271, regarding the Justice Departments position in Texas v. United States HR 2062 & S. 1012, regarding 42 CFR Part 2 and confidentiality of certain health information HR 1884, with provisions to stabilize and strengthen the ACA and the nongroup insurance market. S. 470, regarding a Medicare buy-in option for individuals aged 50-64 S. 489 and HR 1277, regarding a Medicaid buy-in option S. 1129, to establish a single payer system based on Medicare for All. HR 1384, to establish a single payer health care system HR 1425, regarding reinsurance funding under the ACA HR 986 and S. 466, regarding Section 1332 state waiver guidance. HR 1010, regarding Short Term Limited Duration Insurance policies HR 1143, regarding Short Term Limited Duration Insurance policies HR 861, regarding surprise billing

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 1531 Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S. 1895 Lower Health Care Costs Act S. 1266 Protecting Patients from Surprise Medical Bills Act H.R. 3502 Protecting People From Surprise Medical Bills Act H.R. 3630 No Surprises Act H.R. 4223 Protecting Patients from Surprise Medical Bills Act H.R. 861 End Surprise Billing Act of 2019 H.R. 2328 Community Health Investment, Modernization, and Excellence Act of 2019 H.R. 133 Consolidated Appropriations Act, 2021

Client expense: Not reported · Firm income: $180,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including telemedicine and Medicaid Fiscal Accountability Regulation Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions Organ transplant policy generally, including liver transplant distribution methodology S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices Implementation of Children's Hospital Graduate Medical Education program

Client expense: $118,169 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the Recovery Audit Contractor Program "H.R. 2328 - Reauthorizing and Extending America Community Health Act" Surprise Medical Bills "H.R. 3502 - Protecting People from Surprise Medical Bills Act" "H.R. 3630 - No Surprises Act General Monitoring of the CARES Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicaid program reforms, including telemedicine and Medicaid Fiscal Accountability Regulation Implementation of health care reform Section 340B drug pricing program Health care disparities issues generally Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices Implementation of electronic health records regulations generally Telemedicine policy generally, including FCC grant program for telehealth H.R. 5900 (Accelerating Kids' Access to Care Act), all provisions H.R. 7663 (Protecting Access to Post-COVID-19 Telehealth Act of 2020), all provisions S. 4108 (Coronavirus Medicaid Response Act), all provisions Mental health legislation generally H.R. 8283 (Temporary Reciprocity to Ensure Access to Treatment Act), all provisions S. 4421 (Temporary Reciprocity to Ensure Access to Treatment Act), all provisions Childhood vaccines legislation generally H.R. 8476, the Telehealth Improvement for Kids Essential Services Act

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

COVID-19 crisis - Engaged with Congress and the administration to advocate for greater regulatory flexibility and appropriate reimbursement for hospitals through development, passage and ongoing implementation of coronavirus relief legislation: HEROES Act (H.R. 6800) Heroes Act 2.0 (H.R. 925) Health, Economic Assistance, Liability Protection and Schools (HEALS) Act (S. 178) The Consolidated Appropriations Act (H.R. 133) Hospital Provider Relief Fund - Urged Congress to provide additional funding for the Provider Relief Fund. Advocated in Congress and with HHS to revert to initial June guidance defining "lost revenue". Liability protections - Advocated for Congress to include liability protections for health care workers and facilities responding to the COVID-19 crisis. Front-line Health Care Worker Hazard Pay - Advocated for Congress to provide funding to enhance payment for essential health care workers. Hospital Group Purchasing - Offered recommendations and insights to support access to essential personal protective equipment, medications and supplies for hospitals treating patients and supply chain stability for the national response to the COVID-19 crisis. 340B Drug Pricing Program - Urged HHS to act to enforce guidance regarding 340B discounts through contract pharmacies. Vaccine distribution, administration and communications - Advocated to provide states with financial support and other resources to enhance communications and for transparency, including support regarding vaccine distribution, administration and post-market processes, considering both providers needs and states needs. Surprise Billing - Supported inclusion of provisions to provide for an independent dispute resolution process in legislation to address surprise bills (H.R. 3630; H.R. 2328; S. 1895; H.R. 133). Urged Congress to oppose benchmark payment rates in COVID relief legislation. Advocated for passage of the Pasteur Act (S. 4760; H.R. 8920)

Client expense: $160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)